Tim Cullinan

--

Chicago, Illinois, United States

About

4X President's Club Winner

Experience

  • Neurology Sales Specialist II, Midwest Region at Impel Pharmaceuticals
    2021 - Present · 5 yrs 6 mos

    Successfully launched TRUDHESA, an acute migraine therapy in a novel delivery system, to Neurologists in Illinois and Wisconsin Won President’s Club by leading nation in new patients starts and total prescriptions for 2022 Promoted to Sales Specialist II as a result of sales performance and demonstrated leadership Penetrated closed academic centers and accounts in Chicago to access and build advocacy with Neurology KOLs

  • Neuroscience Specialist, Great Lakes Region at Biohaven Pharmaceuticals
    2019 - 2021 · 2 yrs

    Successfully launched oral CGRP receptor antagonist NURTEC ODT® to specialists in Chicago Launching only novel agent with both acute and preventive indications for migraine Developed strong advocacy with key Headache Centers and Neurology Departments in Chicago Leveraged strong local business knowledge to penetrate closed accounts and IDNs in territory

  • Sr. Striker Representative, Chicago Region at Daiichi-Sankyo
    2017 - 2019 · 2 yrs

    Successfully promoted INJECTAFER° to Hematologists, Gastroenterologists & Infusion Centers Launched and promoted abuse-deterrent opioid MORPHABOND ER° to Pain Specialists in Chicago Successfully promoted MOVANTIK° to Pain Specialists, Neurologists, and Orthopedic Surgeons Partnered with hospitals and infusion centers to pull through buy/bill process and savings program

  • Merck & Co., Inc. (11 yrs 1 mo)
    • Executive Customer Representative, Chicago Region
      2008 - 2016 · 8 yrs

      Promoted key portfolio products within Asthma, Allergic Rhinitis, Diabetes, Cardiovascular, Migraine, & Osteoporosis franchises to primary care and specialty physicians in Chicago Consistently exceeded plan on top revenue generating products within portfolio Successfully launched BELSOMRA° in a generic emphasized market Served as training point representative for respiratory and diabetes products within district

    • Senior Respiratory Specialist, Great Lakes District
      2005 - 2008 · 3 yrs

      Chosen by Region Director to promote and grow market share of SINGULAIR° with specialists Built strong rapport with key opinion leaders through role as speaker liaison to achieve medical education goals in respiratory market Enhanced strong working relationships with medical directors, hospital directors, and formulary influencers Key Results and Accomplishments Won 2015 Director’s Award for achieving top 20% rank in national market share for BELSOMRA° launch Won 2014 Director’s Award for regionleading performance in market share change for JANUVIA° Won 2013 Vice President’s Club award by finishing #1 among 98 representatives within region Won 2009 and 2010 Most Valuable Peer award as voted on by teammates within district Exceeded all sales objectives from 2006-2009 by leading district in performance

    • Manager, Medical Strategies & Physician Education
      2005 - 2005 · Less than a year

      Led marketing strategy of external speaker programs for Oncology, Lipid, & Osteoporosis franchises Successfully developed complex content, innovations, metrics, and budget totaling $2.25 million Spearheaded development of strategically consistent medical education content for Oncology Franchise Generated discussion guides for field representatives to support external speaker programs Developed Oncology medical education and ROI analysis for Profit Plan Directed national training teleconferences for new resources

  • Manager, Medical Strategies & Physician Education at Merck/Schering-Plough
    2003 - 2004 · 1 yr

    Managed Content Development Cross Functional Team which included Marketing, MS&PE, Medical Science Liaisons, and MSL Management Created content consistent with brand strategy for launch of VYTORIN° Developed and presented EPI analysis for Profit Plan and Expense Defense Led national speaker liaison training for new resources Member of Physician Promotion Team for VYTORIN° launch